Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors.
(Q53591737)
scientific article published in October 2006
scientific article published in October 2006
Language:
Current Data About
Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors.
other details
description | scientific article published in October 2006 |
External Links
(P356) |
10.1158/1078-0432.CCR-06-0443
|
(P698) |
17062692
|